(Press-News.org) Amsterdam, September 12, 2012 - Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today the publication of a position statement by the European Menopause and Andropause Society (EMAS) in the journal Maturitas. The society published a clinical guide on low-dose vaginal estrogens for postmenopausal vaginal atrophy also including a summary of recommendations.
Vaginal atrophy is common after menopause and adversely affects quality of life in one out of every two women. This guide provides the evidence for the clinical use of low-dose vaginal estrogens for this condition, focusing on publications since the 2006 Cochrane systematic review. The guide concludes that low-dose vaginal estrogens are effective and that there is no need for added progestogens for endometrial protection if topical estrogens are used in the recommended doses. With regard to duration of use, recommendations vary among patients, but vaginal atrophy is a chronic condition and will recur on cessation of treatment. Thus annual review would be prudent.
These and other recommendations presented in the EMAS clinical guide are published in the article: "EMAS clinical guide: Low-dose vaginal estrogens for postmenopausal vaginal atrophy" by Margaret Rees, Faustino R. Pérez-López, Iuliana Ceasu, Herman Depepyre, Tamer Erel, Irene Lambrinoudaki, Karin Schenck-Gustafsson, Tommaso Simoncini, Yvonne van der Schouw, and Florence Tremollieres (10.1016/j.maturitas.2012.06.009). The article appears in Maturitas Volume 73, Issue 2 (October 2012) published by Elsevier.
### About the European Menopause and Andropause Society (EMAS)
The EMAS promotes the study of midlife health through its journal, congresses, schools and website and encourages the exchange of research and professional experience between members. Using a range of activities and through its affiliates, the EMAS aims to guarantee and provide the same standard of education and information throughout Europe on midlife health in both genders. Recognizing the issues arising from increased longevity, the society also provides articles, patient information, web resources, and referrals for healthcare providers in the field and keeps its members up-to-date.
For more information go to: http://www.emas-online.org/
About Maturitas
Maturitas is an international multidisciplinary peer reviewed scientific journal of midlife health and beyond, publishing original research, reviews, consensus statements and guidelines. The scope encompasses all aspects of postreproductive health in both genders ranging from basic science to health and social care. www.maturitas.org
About Elsevier
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby's Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Media contact
Greyling Peoples
Elsevier
+31 20 485 3323
g.peoples@elsevier.com
Maturitas publishes clinical guide on low-dose vaginal estrogens for vaginal atrophy
2012-09-13
ELSE PRESS RELEASES FROM THIS DATE:
Low ghrelin -- reducing appetite at the cost of increased stress?
2012-09-13
Philadelphia, PA, September 13, 2012 – Ghrelin is a hormone released by the lining of the stomach that promotes feeding behavior. Decreasing ghrelin levels could potentially help combat obesity -- in fact, a vaccine that lowers ghrelin levels in order to reduce appetite is being studied as a treatment for obesity.
However, many people eat as a way to relieve stress. If low ghrelin levels increase stress, its effectiveness as a treatment for obesity may be reduced. In the current issue of Biological Psychiatry, researchers led by Dr. Zane Andrews of Monash University in ...
Shine and rise
2012-09-13
Inhibitory neurotransmitters dampen the activity of neurons. This regulatory effect forms the basis for the action of many anesthetics. For example, propofol, a common anesthetic, interacts with receptors on neural cell membranes that normally bind the inhibitory neurotransmitter gamma-amino butyric acid (GABA). Binding of GABA opens protein channels through which negatively charged chloride ions stream into the cell. By raising the resting electrical potential across the membrane, this makes the cell less likely to fire in response to an incoming stimulus. Propofol magnifies ...
People who read food labels stay thinner
2012-09-13
An international team of scientists headed from the University of Santiago de Compostela ensures that reading the labels on food products is linked to obesity prevention, especially in women. According to the study which used data from the USA, female consumers who consult food labels weigh nearly 4 kilograms less.
Along with the Universities of Tennessee, Arkansas (USA) and the Norwegian Institute for Agricultural Finance Research, the University of Santiago de Compostela has participated in a study on the relationship between reading the food label and obesity.
The ...
NIH-funded analysis estimates effective PrEP dosing
2012-09-13
WHAT:
Several large clinical trials have demonstrated that a daily oral dose of one or two antiretroviral drugs used to treat HIV infection can prevent infection in an approach known as pre-exposure prophylaxis, or PrEP. The level of protection, however, depends on taking the drugs regularly. For instance, the landmark iPrEx study (http://www.niaid.nih.gov/news/newsreleases/2010/Pages/iPrEx.aspx) found that overall, men who have sex with men who received a daily dose of tenofovir plus emtricitabine (Truvada) had a 44 percent lower risk of HIV infection compared with ...
Cell death mystery yields new suspect for cancer drug development
2012-09-13
A mysterious form of cell death, coded in proteins and enzymes, led to a discovery by UNC researchers uncovering a prime suspect for new cancer drug development.
CIB1 is a protein discovered in the lab of Leslie Parise, PhD , professor and chair of the department of biochemistry at the University of North Carolina at Chapel Hill. The small calcium binding protein is found in all kinds of cells.
Cassandra Moran, DO, was a pediatric oncology fellow at UNC prior to accepting a faculty position at Duke University. She is interested in neuroblastoma, a deadly form of ...
Computer program can identify rough sketches
2012-09-13
VIDEO:
To develop a program that allows computers to recognize rough sketches, we need to understand how humans actually sketch objects. Researchers from Brown University and the Technical University of Berlin...
Click here for more information.
PROVIDENCE, R.I. [Brown University] — First they took over chess. Then Jeopardy. Soon, computers could make the ideal partner in a game of Draw Something (or its forebear, Pictionary).
Researchers from Brown University and the ...
Effects of stopping alcohol consumption on subsequent risk of esophageal cancer
2012-09-13
Cancer of the oesophagus is becoming more common in Europe and North America. Around 7,800 people in the UK are diagnosed each year. The exact causes of this cancer aren't fully understood. It appears to be more common in people who have long-term acid reflux (backflow of stomach acid into the oesophagus). Other factors that can affect the risk of developing cancer of the oesophagus include:
Gender – It is more common in men than in women.
Age – The risk of developing oesophageal cancer increases as we get older. It occurs most commonly in people over 45.
Smoking ...
U-M guidelines help family physicians evaluate, manage urinary incontinence for women
2012-09-13
ANN ARBOR, Mich. — Millions of women experience a loss of bladder control, or urinary incontinence, in their lifetime.
It's a common and often embarrassing problem that many patients don't bring up with their doctors – and when they do, it may be mentioned as a casual side note during a visit for more pressing medical issues.
Now, new guidelines from doctors at the University of Michigan Health System offer family physicians a step-by-step guide for the evaluation of urinary leakage, to prevent this quality-of-life issue from being ignored.
"I think a lot of physicians ...
Parental divorce linked to stroke in males
2012-09-13
TORONTO, ON – Men with divorced parents are significantly more likely to suffer a stroke than men from intact families, shows a new study from the University of Toronto.
The study, to be published this month in the International Journal of Stroke, shows that adult men who had experienced parental divorce before they turned 18 are three times more likely to suffer a stroke than men whose parents did not divorce. Women from divorced families did not have a higher risk of stroke than women from intact families.
"The strong association we found for males between parental ...
Lack of oxygen in cancer cells leads to growth and metastasis
2012-09-13
It seems as if a tumor deprived of oxygen would shrink. However, numerous studies have shown that tumor hypoxia, in which portions of the tumor have significantly low oxygen concentrations, is in fact linked with more aggressive tumor behavior and poorer prognosis. It's as if rather than succumbing to gently hypoxic conditions, the lack of oxygen commonly created as a tumor outgrows its blood supply signals a tumor to grow and metastasize in search of new oxygen sources – for example, hypoxic bladder cancers are likely to metastasize to the lungs, which is frequently deadly. ...